All Clinitas drops and Clinitas Gel are in stock and can be ordered in the usual way. - January 09, 2024
Product Shop
About
About Us
FAQs
Our Products
Prescription Products
Surgical Products
Retail Products
View all Products
Our Stockists
News & Events
Contact Us
Patient Zone
Common eye conditions
Dry eye explained
Blepharitis explained
Our products
Useful links
+44 (0)1182 210150
About
About
About Us
FAQs
Our Products
Our Products
Prescription Products
Surgical Products
Retail Products
View all Products
Our Stockists
News & Events
Contact Us
Patient Zone
Patient Zone
Common eye conditions
Dry eye explained
Blepharitis explained
Our products
Useful links
+44 (0)1182 210150
Our Products
Dry Eye
Clinitas® 0.4%
Clinitas® 0.4%
The original product, Clinitas was launched in 2007, and continues to be a popular choice due to its unique features and benefits.
0.4% Sodium Hyaluronate eye drops
Phosphate and preservative free
Suitable for contact lens wearers
Resealable daily dose vials (30 x 0.5ml) = 1 per day
Available on prescription
To purchase Clinitas 0.4% Soothe visit
Clinitas.co.uk
Got a question?
Contact us
or
See our FAQ’s
Product details
Product information
Rapid acting and effective relief of dry, gritty or irritated eyes with the highest concentration, 0.4% of hyaluronate lubricant. Each vial is resealable and can be used throughout the day.
Clinitas provides lasting relief from the sensations of dry eye - such as grittiness, burning or foreign body sensation. These can occur either pathologically (e.g. Sjogren's syndrome) or non-pathologically, where there is a deficient and/or unstable tear film. It can also be used after Lasik surgery to ease dryness in the eye but not during surgery itself. Clinitas contains sodium hyaluronate which has mucomimetic muco adhesive and viscoelastic properties to stabilise the tear film and provide gentle, soothing prolonged relief. Clinitas can be used with contact lenses.
Clinitas features and benefits
FEATURES
0.4% Sodium Hyaluronate (HA)
Stays up to 8x longer on the eye than hypromellose
30 x re-sealable 0.5ml unit dose
Preservative-Free
Ergonomically designed vial
NHS Drug Tariff Cost £5.70
10 to 12 drops per vial
BENEFITS
Pharma grade, highest concentration of NaHA available in UK
Boosts, protects, stabilises tear film
Soothing, prolonged relief
Re-use vial for 12 hours (no waste and cost effective)
No protrusions on vial tip = low risk of injury or infection
Value for money - 19p per day
Convenient to carry
Contact lens friendly
Related prescription products
Clinitas® Multi 0.4%
Clinitas Multi is a preservative-free eye drop that contains sodium...
Dry Eye
Clinitas® Gel
Clinitas Gel is a liquid gel for the treatment of...
Dry Eye
Clinitas® Multi 0.2%
Clinitas® Multi 0.2% is a sterile, preservative free, eye drop...
Dry Eye
Clinitas® Antibacterial Eye Compress
A warming eye compress to help relax away the symptoms...
Dry Eye,Dry Eye,Blepharitis
Resealable unit dose vials
Convenient and portable - use as and when required
Clinitas® Sodium Hyaluronate 0.4% is a cost effective, preservative-free eye drop. It is the highest strength sodium hyaluronate product available in the UK. This treatment is dispensed as a carton of 30 resealable units for just £5.70. After the first dose the top of the vial is simply reversed and replaced. The vial may then be re-used for up to 12 hours, making Clinitas an economical and very convenient eye drop.
There are enough drops in each unit to last the day, which means that £5.70 is the true price for 30 days treatment. The price compares favourably to many other non-resealable unit dose products, and some of the more expensive preservative free bottles.
Technical Specification
Product name: Clinitas
Prescription product
Indication: Dry eye
Active ingredient: Sodium Hyaluronate 0.4%
Preservative free: Yes
Phosphate free: Yes
Presentation: 30 x 0.5ml resealable daily dose vials
Once opened: Each vial may be used for 12 hours
Use with contact lenses: Yes
Drug tariff price: £5.75
Can the plastic be recycled?: Yes, the plastic of the monodoses is recyclable
Approved: JB027 MAY 2018